Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC
C.LiK.WangL.MonkJ
These significant studies, however, are provocative and promise to be a springboard for further research
3 While other diabetic treatment options exist, including low carbohydrate diets, physical activity, and other medication options, GLP1 receptor agonists can serve as a powerful tool for diabetic management in individuals who have been unable to achieve desired glycemic control using such options
Our explainer on how tirzepatide influences incretin pathways and the overview at what tirzepatide (Mounjaro/Zepbound) is and how it works walk through the receptor pharmacology